CIK 0001490978 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 255.9 M | 181.0 M | ||
| Net income (USD) | -24.5 M | -24.6 M | ||
| Diluted EPS (USD/shares) | -1.41 | -2.1 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-21 | 4 | FORM 4 | 2026-09-17 |
| 2026-09-17 | 144 | 144 | |
| 2026-08-05 | S-8 | S-8 | |
| 2026-08-05 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 8-K | 8-K items 2.02,9.01 | 2026-08-05 |
| 2026-07-17 | 4 | FORM 4 | 2026-07-16 |
| 2026-07-16 | 144 | 144 | |
| 2026-07-01 | 144 | 144 | |
| 2026-06-29 | 4 | FORM 4 | 2026-06-26 |
| 2026-06-29 | 8-K | 8-K items 7.01 | 2026-06-29 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-22 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-22 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-22 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-22 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-22 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-22 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-22 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-22 |
| 2026-06-23 | 4 | FORM 4 | 2026-06-22 |
| 2026-06-23 | 8-K | 8-K items 5.02,5.07,9.01 | 2026-06-22 |
| 2026-06-08 | 8-K | 8-K items 5.02,9.01 | 2026-06-05 |
| 2026-05-20 | 8-K | 8-K items 5.02,7.01 | 2026-05-18 |
| 2026-05-15 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-05-05 | 10-Q | 10-Q | 2026-03-31 |
| 2026-05-05 | 8-K | 8-K items 2.02,9.01 | 2026-05-05 |
Forms on file (last 1,000): 4 289, 8-K 56, 144 40, 3 31, 10-Q 20, DEFA14A 10, S-8 9, SC 13G/A 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=SDGR (0.002 USD), /gw/filings/filings?ticker=SDGR&form=8-K, /gw/filings/facts?ticker=SDGR&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange